Locations:
SearchAdvertisement
ACC committee underscores need to properly weigh benefits in risk-benefit calculations
Two major trials promise key progress against the last unaddressed major risk factor
Effect on gut microbiome emerges as another benefit of statin therapy
Randomized controlled study undercuts unsubstantiated ‘heart health’ claims
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Increased risk is partly mediated by microbiota-derived metabolites of L-carnitine, choline
Medicare database analysis finds reduced risk of death, heart failure, myocardial infarction and stroke
Targeted mRNA blocking could be first effective approach specific to this cardiovascular risk factor
Provocative findings from a hypothesis-generating study
New review identifies the limited guidance that can be offered
New revision aligns with other major guidelines’ recommendations
Advertisement
Advertisement